Skip to main content
You have permission to edit this article.
Edit
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Sesen Bio Inc (NQ: SESN )

0.7001 -0.0039 (-0.55%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 12, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,186,305
Open 0.7100
Bid (Size) 0.7000 (5)
Ask (Size) 0.7098 (6)
Prev. Close 0.7040
Today's Range 0.6932 - 0.7200
52wk Range 0.3650 - 1.690
Shares Outstanding 196,002,620
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Sesen Bio: Q2 Earnings Insights
  Sesen Bio (NASDAQ:SESN) reported its Q2 earnings results on Monday, August 8, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Sesen Bio Reports Second Quarter 2022 Financial Results and Business Update
From Sesen Bio
Via Business Wire

Performance

YTD
-18.16%
-18.16%
1 Month
-22.22%
-22.22%
3 Month
+69.11%
+69.11%
6 Month
+2.09%
+2.09%
1 Year
-42.61%
-42.61%

More News

Read More
U.S. Stocks Turn Lower; Crude Oil Settles Back Above This Level
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Sesen Bio Pauses Clinical Development Of Its Lead Bladder Cancer Candidate In US
Via Benzinga
Sesen Bio: Q1 Earnings Insights
Via Benzinga
Why Qudian Shares Jumped Over 40%; Here Are 73 Biggest Movers From Yesterday
Via Benzinga
Nasdaq Rises More Than 1%; Housing Market Index Tumbles To This Much Low Level
Via Benzinga
Tesla, Coinbase Global And 41 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Why Shares Of Sesen Bio Are Down 28% Today
Via Benzinga
The Daily Biotech Pulse: Sesen Bio Stops Lead Assest Development In US, FDA Approves Eton Pharma's Partial Seizures Drug, Bavarian Nordic Inks Multiple Supply Pact For Monkeypox Vaccine
Via Benzinga
Sesen Bio Announces Strategic Decision to Pause Clinical Development of Vicineum™ in the US
From Sesen Bio
Via Business Wire
Stocks Selling For Less Than Cash Per Share
Via Talk Markets
33 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
89 Biggest Movers From Friday
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
69 Biggest Movers From Yesterday
Via Benzinga
95 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
77 Biggest Movers From Yesterday
Via Benzinga
Sesen Bio Reports First Quarter 2022 Financial Results and Business Update
From Sesen Bio
Via Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs
Via Benzinga
80 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.